期刊文献+

某地区耐碳青霉烯类抗菌药物肠杆菌科细菌的临床感染状况及耐药性分析 被引量:7

Analysis of infection status and drug resistance to clinically isolated carbapenem-resistant Enterobacteriaceae
原文传递
导出
摘要 目的分析某地区耐碳青霉烯类抗菌药物肠杆菌科细菌(CRE)的检出率、临床感染状况及耐药性,为临床合理治疗提供依据。方法回顾性分析2010年-2016年从临床分离筛选出的177株CRE的临床特点与耐药性,采用Walk Away96全自动微生物分析仪对菌株进行鉴定和药敏试验,采用WHONET 5.6软件对菌株分布及药敏结果进行统计分析。结果 2010年-2016年共分离到肠杆菌科细菌7 580株,其中CRE177株占2.3%。CRE菌株主要来源于痰标本占62.1%,患者所在科室主要为ICU和脑外科,分别占45.8%和22.0%,CRE中种类最多的是肺炎克雷伯菌,占79.1%。CRE对21种抗菌药物的耐药性,除复方新诺明和四环素的耐药率较低,分别为15.3%和28.2%外,对多种抗菌药物保持较高的耐药性,均>75.0%。结论 CRE的检出逐年增加,耐药情况严重,临床应采取措施防止该类菌株的暴发性传播。 Objective To analyze the detection rate and clinical distribution characteristics and drug resistance of carbapenem-resistant Enterobacteriaceae(CRE),so as to provide basis for clinical treatment. Methods 177 strains of CRE were screened from clinical isolates from 2010 to 2016,and its clinical characteristics and resistance were conducted for retrospective analysis.Identification and drug sensitivity tests were carried out using Walk Away96 full automatic microbial analyzer. The strain distribution and drug sensitivity were statistically analyzed by WHONET5. 6 software. Results From 2010 to 2016,a total of 7 580 strains of Enterobacteriaceae were isolated,and 177 strains of CRE accounted for 2. 3%. CRE specimens were from sputum samples,accounting for 62. 1%,and patients mainly came from ICU and Neurosurgery,respectively accounting for 45. 8% and22. 0%,most of the CRE was Klebsiella pneumoniae,accounting for 79. 1%. The drug resistant rates of these CRE were higher than 75. 0% in most of 21 kinds of antibiotics,while that to sulfamethoxazole and tetracycline were respectively 15. 3% and28. 2%. The resistance of CRE to 21 antimicrobial agents was higher,except that to compound sulfamethoxazole and tetracycline(15. 3%,28. 2%),and the resistance of CRE to many antibiotics was high,with the average resistance rate more than75. 0%. Conclusion The detection of CRE is increasing year by year and drug resistance is serious. Measures should be taken to prevent the outbreak of the strain.
作者 支晓阳 林雪峰 ZHI Xiao - yang, LIN Xue - feng(Yueqing Hospital Affiliated to Wenzhou Medical University, Yueqing, Zhejiang 325600, Chin)
出处 《中国卫生检验杂志》 CAS 2018年第9期1063-1066,共4页 Chinese Journal of Health Laboratory Technology
关键词 碳青霉烯类抗菌药物 肠杆菌科细菌 耐药性 Carbapenem antibiotics Enterobacteriaceae Drug resistance
  • 相关文献

参考文献11

二级参考文献146

  • 1骆俊,朱德妹,徐晓刚,吴卫红,王明贵,张婴元,汪复.泛耐药弗劳地柠檬酸杆菌产β内酰胺酶及同源性[J].中华传染病杂志,2006,24(5):291-295. 被引量:20
  • 2Rahal JJ. The role of carbapenems in initial therapy for serious Gram-negative infections[J]. Crit Care, 2008,12 ($4) : 5.
  • 3Yigit H, Queenan AM, Anderson GJ, et al. Novel earbapen- em-hydrolyzing beta-laetamase, KPC-1, from a earbapenem-re- sistant strain of Klebsiella pneumoniae [J]. Antimierob Agents Chemother,2001,45(4) : 1151-1161.
  • 4Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece-a review of the current evi- dence[J]. Euro Surveill, 2008,13 (4), pii : 8023.
  • 5Oteo J, Delgado-Iribarren A, Vega D, et al. Emergence of imipen- em resistance in clinical Escherichia coli during therapy[J], lnt J Antimicrob Agents, 2008,32 (6) : 534-537.
  • 6Kaczmarek FM, Dib-Hajj F, Shang W, et al. High-level carbapen- em resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla (ACT-1) beta-lactamase production ,porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe [J]. Antimicrob Agents Chemoth- er, 2006,50 (10) : 3396-3406.
  • 7Queenan AM, Bush K. Carbapenemases: the versatile beta-lacta- mases[J]. Clin Mierobiol Rev, 2007,20 (3) : 440-458.
  • 8Yigit H, Anderson G J, Biddle JW, et al. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with de- creased expression of OmpF and OmpC porin analogs[J]. Antimi- crob Agents Chemother, 2002,46 ( 12 ) : 3817-3822.
  • 9Villar HE, Danel F, Livermore DM. Permeability to carbapenems of Proteus mirabilis mutants selected for resistance to imipenem or other beta-lactams[J]. J Antimicrob Chemother, 1997,40 (3) : 365-370.
  • 10Castanheira M, Mendes RE, Woosley LN, et al. Trends in car- bapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas : report from the SENTRYantimicrobial surveillance programme (2007-09)[J]. J Antimicrob Chemother, 2011,66(6) : 1409-1411.

共引文献254

同被引文献56

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部